Catalog of 5' fusion partners in

5′ fusion partners NSCLC Pralsetinib RET Selpercatinib Whole-transcriptome sequencing

Journal

JTO clinical and research reports
ISSN: 2666-3643
Titre abrégé: JTO Clin Res Rep
Pays: United States
ID NLM: 101769967

Informations de publication

Date de publication:
Jun 2020
Historique:
received: 29 02 2020
revised: 18 03 2020
accepted: 18 03 2020
entrez: 30 9 2021
pubmed: 30 3 2020
medline: 30 3 2020
Statut: epublish

Résumé

Since the discovery of

Identifiants

pubmed: 34589933
doi: 10.1016/j.jtocrr.2020.100037
pii: S2666-3643(20)30042-4
pmc: PMC8474217
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

100037

Informations de copyright

© 2020 The Authors.

Références

Genome Res. 2012 Mar;22(3):436-45
pubmed: 22194472
Oncol Rep. 2012 Oct;28(4):1187-92
pubmed: 22797671
J Clin Oncol. 2017 May 1;35(13):1403-1410
pubmed: 28447912
J Thorac Oncol. 2020 Apr;15(4):e52-e53
pubmed: 32216946
Cancer Discov. 2018 Jul;8(7):836-849
pubmed: 29657135
Cancer Genet. 2019 Oct;238:10-17
pubmed: 31425920
Lung Cancer. 2019 Dec;138:124-130
pubmed: 31710864
Cancer Manag Res. 2019 Jul 09;11:6343-6351
pubmed: 31372039
Nat Med. 2014 Dec;20(12):1479-84
pubmed: 25384085
J Thorac Oncol. 2018 Jul;13(7):e122-e123
pubmed: 29935851
Ann Oncol. 2018 Aug 1;29(8):1869-1876
pubmed: 29912274
Lung Cancer. 2018 Apr;118:27-29
pubmed: 29571998
Clin Cancer Res. 2014 Jun 15;20(12):3087-93
pubmed: 24727320
Nat Med. 2012 Feb 12;18(3):378-81
pubmed: 22327623
Cancer Discov. 2013 Jun;3(6):630-5
pubmed: 23533264
Ann Oncol. 2017 Feb 1;28(2):292-297
pubmed: 27803005
Lancet Oncol. 2016 Dec;17(12):1653-1660
pubmed: 27825636
Nat Med. 2017 Jun;23(6):703-713
pubmed: 28481359
J Hematol Oncol. 2020 Apr 15;13(1):37
pubmed: 32295619
J Thorac Oncol. 2012 Dec;7(12):1872-1876
pubmed: 23154560
J Thorac Oncol. 2020 Feb;15(2):e27-e28
pubmed: 32127187
Cancer Discov. 2019 Mar;9(3):384-395
pubmed: 30487236
J Thorac Oncol. 2019 Jan;14(1):e7-e9
pubmed: 30579554
Nat Med. 2012 Feb 12;18(3):382-4
pubmed: 22327622
Oncol Res. 2019 May 7;27(5):575-582
pubmed: 30131091
Trends Cancer. 2019 Nov;5(11):677-692
pubmed: 31735287
Cell Rep. 2017 Sep 5;20(10):2368-2383
pubmed: 28877471
J Mol Diagn. 2014 Mar;16(2):229-43
pubmed: 24418728
J Clin Oncol. 2012 Dec 10;30(35):4352-9
pubmed: 23150706
Clin Cancer Res. 2019 Oct 1;25(19):5832-5842
pubmed: 31300450
Oncotarget. 2016 Jun 14;7(24):36101-36114
pubmed: 27150058
Nat Med. 2012 Feb 12;18(3):375-7
pubmed: 22327624
J Thorac Oncol. 2017 Feb;12(2):e15-e16
pubmed: 28115111
Lancet Respir Med. 2017 Jan;5(1):42-50
pubmed: 27825616

Auteurs

Sai-Hong Ignatius Ou (SI)

Chao Family Comprehensive Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of California Irvine School of Medicine, Orange, California.

Viola W Zhu (VW)

Chao Family Comprehensive Cancer Center, Department of Medicine, Division of Hematology and Oncology, University of California Irvine School of Medicine, Orange, California.

Classifications MeSH